TIZANIDINE HYDROCHLORIDE
- Product NDC
- 60760-892
- 11-digit product format
- 607600892
- Labeler code
- 60760
- Product ID
- 60760-892_4009c0a9-d2e0-3595-e063-6294a90aa2a3
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- tizanidine hydrochloride
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- ST. MARY'S MEDICAL PARK PHARMACY
- Application
- ANDA210267
- Marketing category
- ANDA
- Marketing start
- 2019-03-20
- Substance
- TIZANIDINE HYDROCHLORIDE
- Active strength
- 6 mg/1
- Pharmacologic classes
- Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- TIZANIDINE HYDROCHLORIDE
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| TIZANIDINE HYDROCHLORIDE | 6 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | B53E3NMY5C |
| Rxcui | 485484 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 60760-892-30 | TIZANIDINE HYDROCHLORIDE | 30 in 1 BOTTLE, PLASTIC | CAPSULE | 30 | | 1 |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 60760-892-30 | 60760089230 | 30 CAPSULE in 1 BOTTLE, PLASTIC (60760-892-30) | 30 capsule | 2025-09-30 | No | No | Current |